AAAAAA

   
Results: 1-10 |
Results: 10
A prospective clinical and urodynamic study of bladder function during andafter pregnancy
Authors: Nel, JT Diedericks, A Joubert, G Arndt, K
Citation: Jt. Nel et al., A prospective clinical and urodynamic study of bladder function during andafter pregnancy, INT UROGYN, 12(1), 2001, pp. 21-26
Diagnosis and assessment of severity in diabetic peripheral arterial occlusive disease
Authors: Podhaisky, H Arndt, K Hansgen, K Taute, BM
Citation: H. Podhaisky et al., Diagnosis and assessment of severity in diabetic peripheral arterial occlusive disease, PERFUSION, 14(10), 2001, pp. 369
The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution
Authors: Phillips, GR Huang, JK Wang, Y Tanaka, H Shapiro, L Zhang, WD Shan, WS Arndt, K Frank, M Gordon, RE Gawinowicz, MA Zhao, YM Colman, DR
Citation: Gr. Phillips et al., The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution, NEURON, 32(1), 2001, pp. 63-77
Design and initial performance of the CLEO III silicon tracker
Authors: von Toerne, E Alam, MS Alexander, JP Anastassov, A Arndt, K Bean, A Blanc, F Boyd, G Brandenburg, GW Cherwinka, JW Duboscq, JE Eckhart, E Ershov, A Fast, J Foland, AD Hopman, PI Gan, KK Gao, Y Kagan, HP Kane, S Kazkaz, L Kass, R Kim, D Lee, J Magerkurth, AJ Miller, D Miyamoto, J Neustadt, M Oliver, J Pavlunin, V Rush, C Selby, T Severini, H Shipsey, I Skubic, P Smith, T Sterner, P Timm, S Tournear, D Ward, CW Zhang, Q Zhao, X Zoeller, MM
Citation: E. Von Toerne et al., Design and initial performance of the CLEO III silicon tracker, NUCL INST A, 473(1-2), 2001, pp. 17-25
Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles
Authors: Boschelli, DH Wang, YD Ye, F Wu, BQ Zhang, N Dutia, M Powell, DW Wissner, A Arndt, K Weber, JM Boschelli, F
Citation: Dh. Boschelli et al., Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles, J MED CHEM, 44(5), 2001, pp. 822-833
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity
Authors: Boschelli, DH Ye, F Wang, YD Dutia, M Johnson, SL Wu, BQ Miller, K Powell, DW Yaczko, D Young, M Tischler, M Arndt, K Discafani, C Etienne, C Gibbons, J Grod, J Lucas, J Weber, JM Boschelli, F
Citation: Dh. Boschelli et al., Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity, J MED CHEM, 44(23), 2001, pp. 3965-3977
Molecular modification of N-cadherin in response to synaptic activity
Authors: Tanaka, H Shan, WS Phillips, GR Arndt, K Bozdagi, O Shapiro, L Huntley, GW Benson, DL Colman, DR
Citation: H. Tanaka et al., Molecular modification of N-cadherin in response to synaptic activity, NEURON, 25(1), 2000, pp. 93-107
Functional cis-heterodimers of N- and R-cadherins
Authors: Shan, WS Tanaka, H Phillips, GR Arndt, K Yoshida, M Colman, DR Shapiro, L
Citation: Ws. Shan et al., Functional cis-heterodimers of N- and R-cadherins, J CELL BIOL, 148(3), 2000, pp. 579-590
Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner - Commentary
Authors: Arndt, K
Citation: K. Arndt, Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner - Commentary, DERM SURG, 25(12), 1999, pp. 973-973
Design, performance and status of the CLEO III silicon detector
Authors: Fast, J Alam, MS Alexander, J Anastassov, A Arndt, K Bean, A Bebek, C Boyd, R Brandenburg, G Cherwinka, J Darling, C Duboscq, J Gan, KK Gao, Y Hopman, P Kagan, H Kass, R Kim, D Lee, J Menon, N Miller, D Oliver, J Rush, C Severini, H Shipsey, I Skubic, P Spencer, M Timm, S Tourne, E Ward, C Zoeller, M
Citation: J. Fast et al., Design, performance and status of the CLEO III silicon detector, NUCL INST A, 435(1-2), 1999, pp. 9-15
Risultati: 1-10 |